Elsevier

Nitric Oxide

Volumes 104–105, 1 November 2020, Pages 36-43
Nitric Oxide

Myoglobin promotes nitrite-dependent mitochondrial S-nitrosation to mediate cytoprotection after hypoxia/reoxygenation

https://doi.org/10.1016/j.niox.2020.08.005Get rights and content

Highlights

  • Myoglobin is a more efficient nitrite reductase than mitochondrial cytochromes.

  • Myoglobin catalyzes nitrite-dependent S-nitrosation of mitochondria.

  • Partial oxidation of myoglobin enhances nitrite-dependent S-nitrosation.

Abstract

It is well established that myoglobin supports mitochondrial respiration through the storage and transport of oxygen as well as through the scavenging of nitric oxide. However, during ischemia/reperfusion (I/R), myoglobin and mitochondria both propagate myocardial injury through the production of oxidants. Nitrite, an endogenous signaling molecule and dietary constituent, mediates potent cardioprotection after I/R and this effect relies on its interaction with both myoglobin and mitochondria. While independent mechanistic studies have demonstrated that nitrite-mediated cardioprotection requires the presence of myoglobin and the post-translational S-nitrosation of critical cysteine residues on mitochondrial complex I, it is unclear whether myoglobin directly catalyzes the S-nitrosation of complex I or whether mitochondrial-dependent nitrite reductase activity contributes to S-nitrosation. Herein, using purified myoglobin and isolated mitochondria, we characterize and directly compare the nitrite reductase activities of mitochondria and myoglobin and assess their contribution to mitochondrial S-nitrosation. We demonstrate that myoglobin is a significantly more efficient nitrite reductase than isolated mitochondria. Further, deoxygenated myoglobin catalyzes the nitrite-dependent S-nitrosation of mitochondrial proteins. This reaction is enhanced in the presence of oxidized (Fe3+) myoglobin and not significantly affected by inhibitors of mitochondrial respiration. Using a Chinese Hamster Ovary cell model stably transfected with human myoglobin, we show that both myoglobin and mitochondrial complex I expression are required for nitrite-dependent attenuation of cell death after anoxia/reoxygenation. These data expand the understanding of myoglobin's role both as a nitrite reductase to a mediator of S-nitrosation and as a regulator of mitochondrial function, and have implications for nitrite-mediated cardioprotection after I/R.

Introduction

Myoglobin and mitochondria are closely associated in the heart and together form a functional metabolome to sustain cardiac bioenergetics [[1], [2], [3], [4]]. Physiologically, mitochondria consume oxygen, which is coupled to the generation of ATP to supply 99% of the energy required for normal cardiac function. The monomeric heme protein, myoglobin, sustains oxidative phosphorylation through the storage and transport of oxygen to the mitochondrion within the myocyte [5,6]. However, during prolonged periods of ischemia and subsequent reperfusion (I/R), this functional relationship is disrupted and mitochondria and myoglobin both contribute to the pathogenesis of I/R injury [7]. Specifically, mitochondrial ATP generation is diminished during ischemia, leading to depleted free energy supply for cellular homeostasis. Upon reperfusion, the accumulation of reducing substrates and oxygen stimulates excessive mitochondrial reactive oxygen species (ROS) generation, leading to oxidation of mitochondrial protein complexes, the release of cytochrome c, and apoptosis [8,9]. Myoglobin potentiates this reperfusion-induced oxidative damage through its auto-oxidation and catalysis of superoxide generation [10,11].

Nitrite (NO2), the one electron oxidation product of nitric oxide (NO), is an endogenous signaling molecule that confers potent cardioprotection in numerous ex vivo and in vivo cell, isolated heart and animal models of myocardial I/R [[12], [13], [14], [15], [16]]. While the precise mechanisms underlying nitrite's cytoprotective effects after I/R are still being elucidated, two seminal observations implicate myoglobin and mitochondria as independent sub-cellular components that are central to nitrite-mediated protection: 1) nitrite covalently modifies a critical cysteine residue (cysteine 39 of the ND3 subunit) on mitochondrial electron transport chain complex I by S-nitrosation during I/R). This post-translational modification results in the inhibition of electron entry and transport in the mitochondrion, effectively attenuating reperfusion ROS generation and preventing protein oxidation and apoptosis [17,18]. 2) Myoglobin expression is required for nitrite-mediated cardioprotection as demonstrated by the inability of nitrite to decrease infarct size or protect cardiac function in myoglobin knockout mice subjected to myocardial infarction [19,20]. This necessity for myoglobin in nitrite-mediated cytoprotection is attributed to its efficient hypoxic nitrite reductase activity, whereby deoxygenated myoglobin (deoxyMb) reduces nitrite to bioavailable NO via the following reaction:Nitrite + deoxyMb (Fe2+) + H+ → NO + metMb (Fe3+) + OH(k = 12.4 M−1s−1; pH 7, 37 °C)

[21,22].

Despite the recognition that myoglobin-dependent nitrite reduction and mitochondrial S-nitrosation are both required for nitrite-induced cytoprotection, it is unknown whether myoglobin mediates mitochondrial S-nitrosation.

In the context of S-nitrosation, it is important to note that NO does not directly modify reduced protein thiols to form S-nitrosothiols but can be converted to nitrosating species in aerobic conditions [23,24]. Relevant to hypoxic S-nitrosation, nitrite is known to catalyze reductive nitrosylation, involving the reduction of metmyoglobin (Fe3+) by NO [25]. Further, a reductive anhydrase reaction has also been proposed as a potential mechanism in which metheme (Fe3+) proteins react with nitrite. Both these reactions require metheme and result in the formation of the potent nitrosating species dinitrogen trioxide (N2O3) [26,27]. In this regard, heme proteins such as hemoglobin and mitochondrial cytochrome c have been shown to promote S-nitrosation [[28], [29], [30]]. However, the ability of myoglobin to catalyze these reactions in a physiological milieu, with physiological levels of nitrite, and its impact on mitochondrial protein modification has previously not been assessed. Additionally, several studies demonstrate that components of the mitochondrial electron transport chain can directly reduce nitrite to NO [22,28,31], but the efficiency of this activity has never been compared to that of myoglobin.

Herein, we directly compare the nitrite reductase activity of mitochondria and myoglobin and show that myoglobin is a significantly more efficient nitrite reductase. We demonstrate that myoglobin promotes mitochondrial S-nitrosation in purified proteins and in a cell system and demonstrate that this is essential to nitrite-mediated protection from hypoxia/reoxygenation. We discuss the implications of myoglobin-dependent mitochondrial S-nitrosation for the regulation of metabolism in physiology and hypoxic/ischemic disease.

Section snippets

Chemicals and reagents

All chemicals were purchased from Sigma unless otherwise specified. For purified myoglobin experiments, horse heart myoglobin was purchased from Sigma and its concentration measured by visible absorption spectroscopy as previously described [22].

Mitochondrial isolation

Mitochondria were isolated by differential centrifugation, as previously described [32,33] from the hearts of male Sprague-Dawley rats. All rats (male aged 9–12 weeks) were housed and fed ad libitum in compliance with the guidelines of the Animal Care

Myoglobin is a more efficient nitrite reductase than isolated mitochondria

In the first series of experiments we compared the efficiency of isolated mitochondria and purified myoglobin as catalysts of hypoxic nitrite reduction. Isolated rat heart mitochondria (0–20 mg/ml) were first incubated with nitrite (1 mM) in anoxia and NO generation measured in the headspace of the reaction. Consistent with previous reports [28,31,36], isolated mitochondria demonstrated a significant rate of nitrite-mediated NO generation that was dependent on the concentration of mitochondrial

Discussion

The primary findings of this study are that 1) myoglobin is a more efficient nitrite reductase than the mitochondrion and that 2) myoglobin promotes the nitrite-dependent hypoxic S-nitrosation of mitochondrial proteins. The physiological relevance of this biochemistry is demonstrated in the context of ischemia/reperfusion by showing that myoglobin expression significantly enhances nitrite-mediated S-nitrosation and protection after hypoxia/reoxygenation of isolated mitochondria and intact cells

Funding sources

This work was funded by NIH/NHLBI RO1HL133003-01A1 to SS.

Declaration of competing interest

None.

Acknowledgements

We would like to thank Dr. Netanya Y. Spencer for creating the CHO-Mb cells.

References (43)

  • J. Tejero et al.

    Low NO concentration dependence of reductive nitrosylation reaction of hemoglobin

    J. Biol. Chem.

    (2012)
  • S. Basu et al.

    Nitrite reductase activity of cytochrome c

    J. Biol. Chem.

    (2008)
  • A.V. Kozlov et al.

    Nitrite reductase activity is a novel function of mammalian mitochondria

    FEBS Lett.

    (1999)
  • P.R. Castello et al.

    Mitochondrial cytochrome oxidase produces nitric oxide under hypoxic conditions: implications for oxygen sensing and hypoxic signaling in eukaryotes

    Cell Metabol.

    (2006)
  • R.S. Balaban et al.

    Spectroscopic determination of cytochrome c oxidase content in tissues containing myoglobin or hemoglobin

    Anal. Biochem.

    (1996)
  • R.J. Rascati et al.

    Purification and characterization of cytochrome c oxidase from rat liver mitochondria

    J. Biol. Chem.

    (1979)
  • M. Totzeck et al.

    Assessment of the functional diversity of human myoglobin

    Nitric Oxide

    (2012)
  • G. Kristiansen et al.

    Endogenous myoglobin in breast cancer is hypoxia-inducible by alternative transcription and functions to impair mitochondrial activity: a role in tumor suppression?

    J. Biol. Chem.

    (2011)
  • U.B. Hendgen-Cotta et al.

    A novel physiological role for cardiac myoglobin in lipid metabolism

    Sci. Rep.

    (2017)
  • J.B. Wittenberg et al.

    Myoglobin-enhanced oxygen delivery to isolated cardiac mitochondria

    J. Exp. Biol.

    (2007)
  • W. Jassem et al.

    The role of mitochondria in ischemia/reperfusion injury

    Transplantation

    (2002)
  • Cited by (4)

    • Nitric oxide signaling in health and disease

      2022, Cell
      Citation Excerpt :

      Also, there are issues about specificity and the predicted slow predominantly nonenzymatic in vivo kinetics of S-nitrosation. In contrast to phosphorylation, S-nitrosation is quite promiscuous, in particular at high NO fluxes such as after induction of iNOS or following treatment with in vivo nitrosating agents such as nitrite (Chouchani et al., 2017; Quesnelle et al., 2020). Such massive S-nitrosation may be involved in pathophysiological events but also possibly in therapeutic effects of drugs with NO-like bioactivity.

    • Myoglobin: From physiological roles to potential implications in cancer

      2022, Biochimica et Biophysica Acta - Reviews on Cancer
      Citation Excerpt :

      These studies collectively provide evidence for muscle-independent ectopic expression of MB and suggest a functional role of this ectopically expressed MB. In addition to the MB's known functions (i.e. oxygen storage, transport, and facilitated diffusion within muscles [24–26,28,53–56]), new functions have been reported such as scavenging NO, ROS and induction of mitochondrial fusion [38,56–66] (Fig. 2). More interestingly is different functional studies placing MB in the context of tumorigenesis [58,67], a role that still is elusive.

    • iTRAQ-based quantitative proteomic analysis of Pelteobagrus vachelli liver in response to hypoxia

      2022, Journal of Proteomics
      Citation Excerpt :

      MB is a small O2-binding protein that is more suitable than haemoglobin to potentially acquire O2 in response to the hypoxia, and Yang et al. speculated that the existence of O2-bound MB could be a reasonable strategy to increase O2 levels to cope with hypoxia [34]. We found that MB was significantly up-regulated in the livers of P. vachelli under hypoxia conditions, and we suspected that P. vachelli under hypoxic environment increased O2-binding capacity to support mitochondrial respiration [35], and accordingly acquiring more energy. In terms of apoptosis inhibition, the results revealed that under long-term hypoxia, proteins inhibiting apoptosis changed significantly to counter the effects of hypoxia.

    1

    Current address: Department of Biomedical Sciences, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, MI.

    2

    Current address: Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP, 14049–900, Brazil.

    View full text